Pressmeddelanden
REG
Notice of extraordinary general meeting in Coegin Pharma AB (publ)
The shareholders of Coegin Pharma AB, reg. no. 559078-0465, are hereby invited to attend the Extraordinary General Meeting on Wednesday, 22 July 2026 at 2:00 p.m. at Medicon Vill...
REG
Kallelse till extra bolagsstämma i Coegin Pharma AB (publ)
Aktieägarna i Coegin Pharma AB, org. nr 559078-0465 kallas härmed till extra bolagsstämma onsdagen den 22 juli 2026 kl. 14.00 på Medicon Village, Scheeletorget 1, i Lund.
Rätt at...
REG
MAR
Coegin Pharma Announces a Directed Issue of Approx. SEK 6.3 Million and Secures Capital Facility Providing Access to SEK 16 Million
The Board of Directors of Coegin Pharma AB (publ) ("the Company" or "Coegin Pharma") has today resolved to propose that the General Meeting resolve on a directed issue of approxi...
Coegin Pharma receives highly encouraging user feedback from Hårklinikken
Coegin Pharma AB ("Coegin" or the "Company") today announces receiving highly encouraging feedback from Hårklinikken, a leading provider of science-led hair and scalp treatments...
Coegin Pharma enters distribution agreement with LYKO for launch of first VEXIENNE® Follicopeptide® product
Coegin Pharma AB ("Coegin" or the "Company") today announces that the Company has entered into a distribution agreement with LYKO Operations AB, one of the leading beauty retaile...
Coegin Pharma provides NPP-4 development update - INCI registration filed and commercialization preparations on track.
Coegin Pharma AB ("Coegin" or the "Company") today provides an update on the development of NPP-4, the Company's next-generation cosmetic peptide innovation designed to enhance s...
Rapporter
Video
Finansiell kalender
Om Coegin Pharma
Coegin Pharma är ett svenskt innovationsbolag som utvecklar och kommersialiserar avancerade kosmetiska teknologier för hår och hud.
Webbplats
www.coeginpharma.com
Bransch
Bioteknik
Prenumerera
Få löpande information från Coegin Pharma via e-post.
Handelsinformation
Kurs 3,62 SEK (2026-06-26)
Förändring 17,92% (2025-06-26)